BioMedomics and its subsidiaries are currently working on the development of 19 products that fall under the In Vitro Diagnostics markets. GlobalData’s report BioMedomics Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are in the late stage of development.
The main research and development focus of BioMedomics is on nervous system diseases, followed by hematologic diseases, cancer, cardiovascular diseases, infectious diseases, hormonal disorders and nutritional and metabolic diseases.
BioMedomics: Top therapeutic area(s) by pipeline products
For a complete picture of the developmental pipeline for BioMedomics medical devices, buy the report here.